Lisata Therapeutics Stock Filter Stocks by Fundamentals
| LSTA Stock | USD 2.65 0.01 0.38% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Lisata Therapeutics' long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Lisata Fundamentals
| Return On Equity | -0.57 | ||||
| Return On Asset | -0.35 | ||||
| Operating Margin | (21.66) % | ||||
| Current Valuation | (3.04 M) | ||||
| Shares Outstanding | 8.6 M | ||||
| Shares Owned By Insiders | 20.18 % | ||||
| Shares Owned By Institutions | 9.11 % | ||||
| Number Of Shares Shorted | 30.72 K | ||||
| Price To Book | 0.90 X | ||||
| Price To Sales | 22.70 X | ||||
| Revenue | 1000 K | ||||
| Gross Profit | 1000 K | ||||
| EBITDA | (22.23 M) | ||||
| Net Income | (19.98 M) | ||||
| Cash And Equivalents | 72.99 M | ||||
| Cash Per Share | 18.07 X | ||||
| Total Debt | 137 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 22.33 X | ||||
| Book Value Per Share | 2.94 X | ||||
| Cash Flow From Operations | (19.36 M) | ||||
| Short Ratio | 2.09 X | ||||
| Earnings Per Share | (2.30) X | ||||
| Price To Earnings To Growth | (0.02) X | ||||
| Target Price | 16.67 | ||||
| Number Of Employees | 26 | ||||
| Beta | 1.03 | ||||
| Market Capitalization | 22.7 M | ||||
| Total Asset | 35 M | ||||
| Retained Earnings | (548.07 M) | ||||
| Working Capital | 28.96 M | ||||
| Net Asset | 35 M |
About Lisata Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lisata Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lisata Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lisata Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| VALE | Vale SA ADR | |
| EGY | Vaalco Energy | |
| CMCSA | Comcast Corp |
Check out Lisata Therapeutics Piotroski F Score and Lisata Therapeutics Altman Z Score analysis. For information on how to trade Lisata Stock refer to our How to Trade Lisata Stock guide.You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Healthcare space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lisata Therapeutics. If investors know Lisata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lisata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lisata Therapeutics is measured differently than its book value, which is the value of Lisata that is recorded on the company's balance sheet. Investors also form their own opinion of Lisata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Lisata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lisata Therapeutics' market value can be influenced by many factors that don't directly affect Lisata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lisata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lisata Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lisata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.